Horizon Therapeutics Public Limited Company provided earnings guidance for the full-year 2022. For the period, the company now expects full-year 2022 net sales to range between $3.53 billion and $3.60 billion, updated from the previous guidance range of $3.9 billion to $4.0 billion.